F085 Diversity, Equity, and Inclusion
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This symposium aims to highlight the importance of diversity, equity and inclusion in dermatology and research. It will also highlight considerations of the healthcare needs of diverse patient populations. This session is intended for a broad audience, where we hope to engage in valuable discussion and consider diversity of thought and experiences as they pertain to these topics. The session will feature current leaders in this work and will present opportunities for participants to learn more about and support this work as it relates to personal relationships, mentorship, sponsorship, research, education and advocacy.
LEARNING OBJECTIVES
Discuss the importance of diversity, equity and inclusion (DEI) in dermatology and research.
Discuss steps to improve inclusion, advocacy and care for religious minorities, sexual and gender diverse, and American Indian and Alaska Native populations.
SCHEDULE
8:00 PM
What the AAD is doing to promote DEI
Susan C. Taylor, MD, FAAD
8:15 PM
Pathway Programs
Henry W. Lim, MD, FAAD
8:30 PM
Impact of the SCOTUS decision on DEI initiatives
Arturo P Saavedra, MD, PhD, FAAD
8:45 PM
Considerations for inclusion, advocacy, and care for sexual and gender diverse populations in dermatology
Jon Klint Peebles, MD, FAAD
9:00 PM
Dermatologic care of American Indian and Alaska Native populations
Shannon Watson Zullo, MD
9:15 PM
Care of religious minorities in the US
Nour Kibbi, MD, FAAD
9:30 PM
The use of terminology for patients in research
Mya L. Roberson
9:45 PM
Diversity in clinical trials
Junko Takeshita, MD, PhD, FAAD
SPEAKERS
Nour Kibbi, MD, FAAD
Henry W. Lim, MD, FAAD
Janiene Luke, MD, FAAD
Jon Klint Peebles, MD, FAAD
E. Nikki Pritchett, MPH, MD, FAAD
Mya L. Roberson
Arturo P Saavedra, MD, PhD, FAAD
Junko Takeshita, MD, PhD, FAAD
Susan C. Taylor, MD, FAAD
Shannon Watson Zullo, MD
HANDOUTS
SPEAKER DISCLOSURES
Nour Kibbi, MD, FAAD
No financial relationships exist with ineligible companies.
Henry W. Lim, MD, FAAD
Beiersdorf, Inc. – Consultant(Fees); Cantabria Labs – Speaker(Fees); Eli Lilly – Consultant (1099 relationship)(Honoraria); Ferndale Laboratories, Inc. – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); ISDIN – Consultant(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); La Roche-Posay – Investigator(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – Speaker/Faculty Education(Fees); Laboratoire Dermatologiques d'Uriage – Speaker/Faculty Education(Honoraria); NAOS – Speaker(Fees); Patient-Centered Outcomes Research Institute – Investigator(Grants/Research Funding); PCORI – Investigator(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Pierre Fabre – Speaker(Fees); Primus Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Skinosive – Consultant (1099 relationship)(Fees); Zerigo Health – Consultant (1099 relationship)(Honoraria);
Janiene Luke, MD, FAAD
Eli Lilly – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria);
Jon Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
E. Nikki Pritchett, MPH, MD, FAAD
Kimberly Clark – Consultant (1099 relationship)(Fees);
Mya L. Roberson
No financial relationships exist with ineligible companies.
Arturo P Saavedra, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Junko Takeshita, MD, PhD, FAAD
Incyte – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding);
Susan C. Taylor, MD, FAAD
AbbVie – Advisory Board(Honoraria); Allergan Aesthetics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant(Honoraria); Armis Biopharma, Inc. – Advisory Board(No Compensation Received); Avita Medical – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(No Compensation Received), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Biorez, Inc. – Advisory Board(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Catalyst Medical Education LLC – Speaker/Faculty Education(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Dermsquared – Speaker/Faculty Education(Honoraria); Dior – Consultant(Honoraria); Eli Lilly and Company – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); EPI Health – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Evolus, Inc. – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria); GloGetter, Inc – Advisory Board(No Compensation Received); Hugel – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Johnson & Johnson Innovative Medicine – Advisory Board(No Compensation Received); L'Oreal – Advisory Board(No Compensation Received); L'Oreal USA Inc. – Advisory Board(Honoraria), Advisory Board(No Compensation Received); LearnSkin – Speaker/Faculty Education(Honoraria); Medscape – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Mercer Strategies, PA, LLC – Board of Directors(Honoraria), Employee(Fees); MJH Life Sciences – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Piction Health – Advisory Board(No Compensation Received); Sanofi – Consultant(Honoraria); Scientis – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria);
Shannon Watson Zullo, MD
No financial relationships exist with ineligible companies.